Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Olema Pharmaceuticals, Inc. | Director | Common Stock | 386K | $5.02M | $13.00 | Mar 5, 2024 | Indirect |
Olema Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 23K | Jun 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OLMA | Olema Pharmaceuticals, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
OLMA | Olema Pharmaceuticals, Inc. | Mar 5, 2024 | 2 | $0 | 4 | Mar 6, 2024 | Director |
OLMA | Olema Pharmaceuticals, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director |
OLMA | Olema Pharmaceuticals, Inc. | Jun 17, 2022 | 1 | $0 | 4/A | Jun 27, 2022 | Director |
OLMA | Olema Pharmaceuticals, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
OLMA | Olema Pharmaceuticals, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |